Ceva

Together, beyond animal health

Ultifend IBD ND - Ceva

DESCRIPTION

ULTIFENDTM IBD ND contains a genetically engineered Marek’s disease vaccine of serotype 3 (turkey herpesvirus or HVT ) expressing infectious bursal disease and Newcastle disease key protective antigens. The Marek’s disease vaccine containing serotype 3 is presented in a frozen cell associated form. The cells and virus particles are very fragile and require careful handling to prevent damage or loss of titer in order to achieve optimum efficacy. The vaccine is stored and shipped in frozen form in liquid nitrogen.

STORAGE CONDITIONS

Vaccine ampules: Store in liquid nitrogen
Diluent: Store at room temperature between 68 - 77°F (20 - 25°C)

INDICATIONS

This product has been shown to be effective for the vaccination of healthy embryonated chicken eggs 18 to 19 days of age and healthy chickens 1 day of age or older against standard bursal disease, Newcastle disease and Marek’s disease. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov. Good management practices are recommended to reduce exposure to bursal disease virus, Newcastle disease virus and Marek’s disease virus for at least 2 weeks following vaccination.

PREPARATION AND ADMINISTRATION OF VACCINE

Carefully read the directions before use. The instructions must be completely followed. Match the vaccine dose size to the proper diluent size and route of administration as follows:

1. For subcutaneous injection of day-old chicks: Mix 200 ml of diluent for each 1000 doses of vaccine.
2. For in ovo vaccination of 18- to 19-day-old chicken embryos: Mix 100 ml of diluent for each 1000 doses of vaccine to administer 0.1 ml per chicken embryo or mix 50 ml for each 1000 doses of vaccine to administer 0.05 ml per chicken embryo.

VACCINE PREPARATION

1. Be familiar with all safety and precautionary measures for handling liquid nitrogen to prevent personal injury.
2. Wear gloves, a plastic face shield, and protective goggles before removing vaccine ampules from the liquid nitrogen.
3. Check the container to confirm a sufficient amount of liquid nitrogen is present to keep the vaccine frozen. If thawed, do not use the vaccine. The containers (Dewars) must be checked regularly for liquid nitrogen level and must be refilled as needed.
4. After matching the dose size of the vaccine with the diluent size, quickly remove the exact number of ampules needed.
5. A maximum of 3 ampules should be thawed at one time. After inspecting the diluent and completing all preparations, the vaccine should be quickly removed from the Dewar and placed into a clean 80°F (26.5°C) thaw bath. This step can be repeated until the appropriate dosage has been reached.Gentle agitation during the thawing process promotes rapid, uniform thawing and evenly distributes the vaccine in the ampule.
6. Immediately after thawing, mix the vaccine with the diluent at room temperature (68°-77°F or 20°-25°C). Gently draw the vaccine from the ampule with an 18-gauge, 1.5 inch needle and slowly mix with the diluent. Rinse the ampule one time with the diluted vaccine.
7. Immediately use the vaccine and mix occasionally to ensure uniform suspension of cells.

SUBCUTANEOUS VACCINATION

1. For subcutaneous injection, sterilize the automatic syringe, needles and other accessory equipment by autoclaving or boiling prior to vaccination.
2. Use a short (3/8 inch or 1/2 inch) 20-gauge needle for vaccination. Subcutaneously inject 0.2 ml into the back of the neck of each chick.

IN OVO VACCINATION

1. The vaccine is administered in ovo to 18- to 19-dayold embryonated eggs. Read the egg injection system operator’s manual before initiating vaccination. Failure to follow instructions may result in personal injury, excessive embryonic mortality and low hatchability. Inoculate each embryo with 1 full dose (0.05 ml or 0.1 ml).
2. Sanitize the egg injection system before and after use following the procedures described in the operator’s manual.

NOTICE

This vaccine has been thoroughly tested for safety, purity, potency and sterility and is in compliance with all applicable USDA and Ceva standards.

CAUTION

1. Read the above directions carefully.
2. Do not vaccinate within 21 days before slaughter.
3. The vaccine contains gentamicin and amphotericin B as preservatives.
4. Inactivate unused contents before disposal.
5. Do not remove vaccine from liquid nitrogen until ready for use
6. Do not refreeze the vaccine.
7. Use entire contents when first opened.
8. Do not use vaccine that has thawed in the liquid nitrogen container.
9. Do not overdose or over dilute the vaccine.
10. Do not mix with other products, except as specified on this label.
11. In case of human exposure, contact a physician.
12. For use in animals only.

If you wish to contact Ceva please visit their contact page


GENERAL REMINDER:
Product indications, usage instructions & withdrawal periods may vary by Country.
Always follow label instructions and consult your veteriarian or poultry health adviser.

This page contains information on veterinary pharmaceutical and biological products that are sold in several different countries and areas where they may be marketed under different trade names and pursuant to different regulatory approvals. Accordingly, ThePoultrySite and CEVA SANTE ANIMALE give no guarantee that the details presented are correct with respect to all locations.

Advertisments and/or reference to commercial products or trade names within information provided by ThePoultrySite.com does not constitute an endorsement by ThePoultrySite.com and does not imply discrimination against any other similar products. This information is aimed at veterinary surgeons, veterinary nurses, pharmacists or professional keepers of poultry.

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.